Accenture (ACN)
(Delayed Data from NYSE)
$330.12 USD
+1.44 (0.44%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $330.30 +0.18 (0.05%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$330.12 USD
+1.44 (0.44%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $330.30 +0.18 (0.05%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
Zacks News
Years of investment in digital, cloud and security strategy has helped Accenture evolve as a trusted and viable consulting services provider. It is currently the world’s top consultancy firm by revenues that increased 5% in 2019 with a contribution of 56% from consulting services.
Accenture (ACN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Accenture (ACN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accenture (ACN) Boosts Interactive Suite With Adaptly Buyout
by Zacks Equity Research
The acquisition is likely to boost Accenture's (ACN) Communications, Media & Technology segment.
Accenture Opens 11th North America Innovation Hub in Atlanta
by Zacks Equity Research
Accenture (ACN) strengthens North American footprint with innovation hub in Atlanta.
Oracle (ORCL) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Oracle (ORCL) benefits from the strong adoption of its cloud-based solutions.
Will Top-Line Growth Support Ciena's (CIEN) Q4 Earnings?
by Zacks Equity Research
Ciena (CIEN) is likely to beat earnings estimates in the fiscal fourth quarter on the back of higher revenues on a year-over-year basis.
Interpublic (IPG) Stock Up 13.6% Year to Date: Here's Why
by Zacks Equity Research
Interpublic's (IPG) digital capabilities, diversified business model and geographic reach offer distinctive competitive advantage.
Waste Connections (WCN) Acquires American Disposal Services
by Zacks Equity Research
The acquisition of American Disposal Services is expected to expand Waste Connections' (WCN) geographic footprint and boost the top line.
Why the Earnings Surprise Streak Could Continue for Accenture (ACN)
by Zacks Equity Research
Accenture (ACN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Hold WEX Stock in Your Portfolio Now
by Zacks Equity Research
WEX continues to benefit from solid organic growth and strategic acquisitions.
Adobe Systems (ADBE) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Adobe's (ADBE) fiscal fourth-quarter results are likely to be driven by strength in Creative Cloud.
The Zacks Analyst Blog Highlights: Verizon, Eli Lilly, Accenture, VMware and Schwab
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Verizon, Eli Lilly, Accenture, VMware and Schwab
Top Stock Reports for Verizon, Eli Lilly & Accenture
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Verizon (VZ), Eli Lilly (LLY) and Accenture (ACN).
III or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
III vs. ACN: Which Stock Is the Better Value Option?
Accenture Completes Kolle Rebbe Buyout, Focuses on Germany
by Zacks Equity Research
The Kolle Rebbe acquisition to boost Accenture's (ACN) Communications, Media & Technology segment.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture
Accenture Opens Innovation Hub in Canada, 800 Jobs in Focus
by Zacks Equity Research
The innovation hub is expected to complement Accenture's (ACN) robust growth in North America.
Top Analyst Reports for Johnson & Johnson, Thermo Fisher & Goldman Sachs
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Thermo Fisher (TMO) and Goldman Sachs (GS).
Accenture Brings Open Partner Ecosystem for Drug Discovery
by Zacks Equity Research
The ecosystem backed by cloud-based informatics research platform is likely to drive Accenture's (ACN) Products Segment.
IT vs ACN: Which Consulting Services Stock is Better Placed?
by Zacks Equity Research
A faster share price rally led to rich valuation for Gartner (IT) compared with Accenture (ACN).
Accenture (ACN) Opens Innovation Hub, Aims to Add 300 Jobs
by Zacks Equity Research
Accenture (ACN) strengthens North American footprint with innovation hub in Seattle.
Accenture Completes Kaplan Buyout, Boosts Nordics Presence
by Zacks Equity Research
The acquisition of Kaplan is a part of Accenture (ACN) Interactive's bid to boost Nordics presence.
Genpact (G) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Genpact's (G) third-quarter 2018 earnings and revenues improve on a year-over-year basis.
Accenture (ACN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $158.58, marking a +0.61% move from the previous day.
Why Is Accenture (ACN) Down 9.2% Since Last Earnings Report?
by Zacks Equity Research
Accenture (ACN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's How IQVIA Will Benefit From Genomics England Allaince
by Zacks Equity Research
IQVIA's (IQV) partnership with Genomics England is expected to boost the Technology & Analytics Solutions segment.